Redsense Medical AB’s shares to begin trading at OTCQX on September 29, 2023

Redsense Medical AB has been qualified and approved to enter share trading on the OTCQX trading platform in the United States. Trading of the share on OTCQX will start September 29, 2023 under the symbol “RDSNF”.

OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"We are excited to now offer U.S. investors the opportunity to begin trading the Redsense Medical share. Furthermore, through a cross-trade on OTCQX, we make it easier for international investors and institutions who are considering trading our shares. With most of our revenue in the U.S. and our strong focus on this market, the dual-quotation is a natural step to meet an increased interest in Redsense Medical”, says Pontus Nobréus, CEO of Redsense Medical AB. 

 B. Riley Securities Inc. acted as the company’s OTCQX sponsor.